Companies / BOC Sciences / Milatuzumab
BOC Sciences

Milatuzumab | BOC Sciences

Milatuzumab is a humanized monoclonal antibody that targets CD74. Milatuzumab reduced proliferation, alterations in migration, and adhesion molecule expression preferentially of CD27- na?ve B cells. Milatuzumab is used for the treatment of multiple myeloma, non-Hodgkin's lymphoma and chronic lymphocytic leukemia.

Reviews


No reviews yet

ABOUT THE COMPANY

BOC Sciences specializes in small molecule synthesis, biosynthesis, purification, and characterization. It provides a wide range of research chemicals and biochemicals, including inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities and metabolites, APIs, natural compounds, ADCs, stem cell molecules and chiral compounds.